Title : Ibrutinib treatment improves T cell number and function in CLL patients.

Pub. Date : 2017 Aug 1

PMID : 28714866






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Ibrutinib has been shown to have immunomodulatory effects by inhibiting Bruton"s tyrosine kinase (BTK) and IL-2-inducible T cell kinase (ITK). ibrutinib IL2 inducible T cell kinase Homo sapiens
2 BACKGROUND: Ibrutinib has been shown to have immunomodulatory effects by inhibiting Bruton"s tyrosine kinase (BTK) and IL-2-inducible T cell kinase (ITK). ibrutinib IL2 inducible T cell kinase Homo sapiens